Ardy is CEO & co-founder of SEQSTER, the leading healthcare technology company that puts the patient at the center of all their health data. He is a visionary health tech executive with 20+ years driving innovation in life sciences and digital health. SEQSTER was founded in 2016 with the mission of positively impacting patient lives at scale by removing the barriers to health data access. Prior to starting SEQSTER, Ardy launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics, and served as SVP of Ambry Genetics, which sold to Konica in 2017 for $1 Billion.